MEDIX RESOURCES INC
NT 10-K, 1999-03-29
HELP SUPPLY SERVICES
Previous: MINDEN BANCSHARES INC, DEF 14A, 1999-03-29
Next: STERLING BANCSHARES INC, 10-K405, 1999-03-29





                                   Form 12b-25

                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20459

                                   FORM 12B-25

                           NOTIFICATION OF LATE FILING

                                  (Check One):
[X]Form 10-K and 10-KSB [ ]Form 20-F [ ]Form 11-K [ ]Form 10-QSB [ ]Form N-SAR
   For Period Ended: December 27, 1998
      [ ] Transition  Report on Form 10-K [ ] Transition Report on Form 20-F [ ]
      Transition  Report  on Form  11-K [ ]  Transition  Report on Form 10-Q [ ]
      Transition Report on Form N-SAR
      For the Transition Period Ended:                                       


   Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.
   Nothing in this form shall be construed to imply that the  Commission  has
   verified any information contained herein.


   If the  notification  related to a portion of the  filing  checked  above,
   identify the Item(s) to which the notification relates:




Part I-Registrant Information


      MEDIX RESOURCES, INC.
      (Full name of Registrant)
- -------------------------------------

      7100 E BELLEVIEW AVENUE, SUITE 301
      (Address of Principal Executive Office)

- -------------------------------------
      ENGLEWOOD, COLORADO   80111
      (City State Zip)

Part II.Rules 12b.25(b) and (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b.25(b), the following should
be completed. (Check box if appropriate)

      (a) The reasons  described in  reasonable  detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

X     (b) The  subject  annual report,  semi-annual report, transition report on
          Form 10.K,  Form 10-KSB, Form  20-F,  11.K or Form  N.SAR,  or portion
          thereof  will  be  filed   on  or  before  the  fifteenth calendar day
          following the prescribed due date; or the subject  quarterly report or
          transition report on Form 10.Q or Form 10-QSB, or portion thereof will
          be  filed on or before the fifth calendar day following the prescribed
          due date; and

X     (c) The accountant's statement or other exhibit required by Rule 12b.25(c)
          has been attached if applicable.


<PAGE>



Part III. Narrative


State below in  reasonable  detail the  reasons why Form 10-K and 10-KSB,  20-F,
11-K, 10-Q and 10-QSB,  N-SAR or the transition  report or portion thereof could
not be filed within the prescribed time period.

      The audit fee for the prior year was  unpaid  until  March 24,  1999 which
      prohibited the  independent  auditors' from beginning  their audit in time
      sufficient  to issue their  opinion  within 90 days of the current  fiscal
      year end.


Part IV. Other Information

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification

        John P. Yeros                  (303)             741-2045
           (Name)                   (Area Code)      (Telephone Number)

(2)  Have all other periodic  reports  required under section 13 or 15(d) of the
     Securities Exchange Act of 1934 or section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such report(s) been filed? If the answer is
     no,  identify  report(s).  [X] Yes [ ] No (3) Is it  anticipated  that  any
     significant  change in results of operations from the corresponding  period
     for the last fiscal year will be reflected by the earnings statements to be
     included in the subject report or portion thereof? [ ] Yes [X] No

     If so, attach an explanation of the anticipated  change,  both  narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.


                              MEDIX RESOURCES, INC.

has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.

Date March 29,  1999 /s/ John P. Yeros,  Chairman  and Chief  Executive  Officer
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.


                                    ATTENTION
      Intentional misstatements or omissions of fact constitute
      Federal Criminal Violations (See 18 U.S.C. 1001).










                                 March 29, 1999



U.S. Securities and Exchange Commission
Washington DC  20549

Dear Sir/Madam:

I have read Form 12b-25 for Medix Resources,  Inc. for a 15 day extension on its
Form 10-KSB for the year ended December 27, 1998, and I concur with the Part III
narrative.

                                   Sincerely,



                                   /s/ Dave Steiner, Principal
                                       Dave Steiner, Principal
                                       Ehrhardt Keefe Steiner & Hottman PC

DJS/acf
Enclosures





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission